The insurance industry is at a pivotal moment, grappling with the transformative potential of artificial intelligence while navigating the ethical challenges it presents. As insurers strive to enhance ...
Early-Stage Breast Cancer in Women Younger Than 50 Years: Comparing American Joint Committee on Cancer Anatomic and Prognostic Stages With Partitioning Around Medoids Clusters in SEER Data Large ...
Real-World and Clinical Trial Validation of a Deep Learning Radiomic Biomarker for PD-(L)1 Immune Checkpoint Inhibitor Response in Advanced Non–Small Cell Lung Cancer The authors present a score that ...
Every week, I see another headline about an AI model achieving “96% accuracy” in healthcare or finance. The press releases are exciting, the demos look impressive and stakeholders are eager to deploy.